Latest News & Features
Refine Search
Americas
 Experts at LSPN North America Fall explore the often-overlooked factors that can make or break transactions, from employee retention strategies to cross-border patent standards.   23 October 2025 
Americas
 Parties impacted by exclusion orders need to carefully weigh their options for seeking clarity or rulings on redesigns, explain Daniel Muino and Charles Provine from Morrison Foerster.   23 October 2025 
Americas
 The Supreme Court’s 2023 Amgen ruling turned patent strategy upside down. Now lawyers are rethinking everything they thought they knew about protecting inventions. Marisa Woutersen reports from LSPN North America–Fall.   22 October 2025 
Biotechnology
 Chuck Scholtz, head of IP at Verdiva Bio, shares the pressures of global filing strategies on tight budgets, why there’s no ‘right way’ to manage IP, and how to get the best results from external counsel relationships.   22 October 2025 
Americas
 Just weeks into his tenure, USPTO director John Squires is blitzing US patent policy by taking control of how and when patent challenges can be brought, with proposed rules that could sharply limit repeat and parallel filings. Sarah Speight gauges reaction.   22 October 2025 
Americas
 Isomorphic Labs' head of IP shares why the first wave of AI-driven drug development stumbled, how data became pharma's most valuable currency, and why inventorship questions could make or break billion-dollar deals in machine learning.   21 October 2025 
Careers
 Hire brings trade secrets and AI litigation expertise from Cooley as firm adds 14th US litigation partner this year.   21 October 2025 
Americas
 LSIPR is gearing up for the 5th annual LSPN North America Fall Conference, starting October 21, in San Francisco, California.   21 October 2025 
Americas
 The Japanese pharmaceutical company has filed a cluster of lawsuits against generic drug makers asserting its patent protection and market exclusivity over the high-selling ALS treatment.   20 October 2025 
Americas
 A US Senate subcommittee hearing on patent eligibility reform has David Kappos, former USPTO director, believing that “there’s a better chance than ever” of a pending bill becoming law, finds Sarah Speight.   17 October 2025 
%201.JPG/r%5Bwidth%5D=320&r%5Bheight%5D=180/e7040970-b002-11f0-9979-9313e8aa9ba8-Panel%202%20-%20Mastering%20Art%20of%20IP%20Transactions%20(Kilburn%20%26%20Strode%20Sponsored)%201.webp)

%203.JPG/r%5Bwidth%5D=320&r%5Bheight%5D=180/fd604e70-af5a-11f0-83fb-1beb2f793d83-Panel%201%20-%20Enabling%20Success%20(Greenberg%20Traurig%20Sponsored)%203.webp)